Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254178405> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4254178405 endingPage "445" @default.
- W4254178405 startingPage "444" @default.
- W4254178405 abstract "Background: It is known that factors other than thyroid-stimulating hormone, such as insulin-like growth factor-I (IGF-I) and epidermal growth factor, have a goitrogenic effect. It has been established that insulin-like growth factor-binding proteins (IGFBPs) may play a role as autocrine/paracrine factors in regulating the local actions of IGFs. Both an inhibitory and a stimulatory effect for different IGFBPs have been shown in several cell systems. The aim of this study was to assess the involvement of IGFBPs in the goitrogenic process in patients with goiter recurrence. Methods: The IGFBP-1 and –3 content in normal and nodular tissues obtained at the time of thyroidectomy from 10 patients with recurrent goiters, unresponsive to thyroid-stimulating hormone suppressive therapy, was studied. In all patients, a fragment of normal tissue was also obtained. The IGF-I, IGFBP-1, and –3 content was evaluated by specific immunoassays and/or immunoblotting with anti-IGFBP specific antiserum. Results: The IGF-I content was significantly higher (P <.05) in nodular tissues (8.0 ± 1.6 ng/g of tissue) than what was found in normal tissue (4.8 ± 0.9 ng/g). Radioimmunoassay IGFBP-3 concentration in nodular tissue was 111.5 ± 18.2 ng/g significantly higher (P <.001) than values found in normal tissue (77.5 ± 18.6 ng/g). By immunoblot, IGFBP-1 appeared higher in all but 1 nodular tissue. Conclusions: These data raise the possibility that IGFBPs are important in the proliferative activities entailed in the goitrogenic process. Three mechanisms are potentially involved: (1) reduction of the potency of locally produced IGF peptide to downregulate type I receptors (potentiating effect on the autocrine/paracrine mitogenic action of IGFs); (2) increase of the IGF-I tissue concentration restraining its passage to circulation; and (3) protection of IGF-I from degradation. Further studies are needed to define a more precise link between these factors and the recurrence of goiter. (Surgery 2000:127:99-103.)" @default.
- W4254178405 created "2022-05-12" @default.
- W4254178405 date "1991-07-01" @default.
- W4254178405 modified "2023-10-01" @default.
- W4254178405 title "The placenta and fetal growth in twin pregnancy late in gestation" @default.
- W4254178405 doi "https://doi.org/10.1016/0143-4004(91)90486-y" @default.
- W4254178405 hasPublicationYear "1991" @default.
- W4254178405 type Work @default.
- W4254178405 citedByCount "0" @default.
- W4254178405 crossrefType "journal-article" @default.
- W4254178405 hasConcept C126322002 @default.
- W4254178405 hasConcept C128240485 @default.
- W4254178405 hasConcept C134018914 @default.
- W4254178405 hasConcept C170493617 @default.
- W4254178405 hasConcept C172680121 @default.
- W4254178405 hasConcept C176685330 @default.
- W4254178405 hasConcept C2775960820 @default.
- W4254178405 hasConcept C2776254400 @default.
- W4254178405 hasConcept C2776362946 @default.
- W4254178405 hasConcept C2776953305 @default.
- W4254178405 hasConcept C2777074255 @default.
- W4254178405 hasConcept C2778288131 @default.
- W4254178405 hasConcept C2779234561 @default.
- W4254178405 hasConcept C2780378035 @default.
- W4254178405 hasConcept C2780689927 @default.
- W4254178405 hasConcept C46973012 @default.
- W4254178405 hasConcept C526584372 @default.
- W4254178405 hasConcept C54355233 @default.
- W4254178405 hasConcept C71315377 @default.
- W4254178405 hasConcept C71924100 @default.
- W4254178405 hasConcept C7876069 @default.
- W4254178405 hasConcept C80862487 @default.
- W4254178405 hasConcept C86803240 @default.
- W4254178405 hasConceptScore W4254178405C126322002 @default.
- W4254178405 hasConceptScore W4254178405C128240485 @default.
- W4254178405 hasConceptScore W4254178405C134018914 @default.
- W4254178405 hasConceptScore W4254178405C170493617 @default.
- W4254178405 hasConceptScore W4254178405C172680121 @default.
- W4254178405 hasConceptScore W4254178405C176685330 @default.
- W4254178405 hasConceptScore W4254178405C2775960820 @default.
- W4254178405 hasConceptScore W4254178405C2776254400 @default.
- W4254178405 hasConceptScore W4254178405C2776362946 @default.
- W4254178405 hasConceptScore W4254178405C2776953305 @default.
- W4254178405 hasConceptScore W4254178405C2777074255 @default.
- W4254178405 hasConceptScore W4254178405C2778288131 @default.
- W4254178405 hasConceptScore W4254178405C2779234561 @default.
- W4254178405 hasConceptScore W4254178405C2780378035 @default.
- W4254178405 hasConceptScore W4254178405C2780689927 @default.
- W4254178405 hasConceptScore W4254178405C46973012 @default.
- W4254178405 hasConceptScore W4254178405C526584372 @default.
- W4254178405 hasConceptScore W4254178405C54355233 @default.
- W4254178405 hasConceptScore W4254178405C71315377 @default.
- W4254178405 hasConceptScore W4254178405C71924100 @default.
- W4254178405 hasConceptScore W4254178405C7876069 @default.
- W4254178405 hasConceptScore W4254178405C80862487 @default.
- W4254178405 hasConceptScore W4254178405C86803240 @default.
- W4254178405 hasIssue "4" @default.
- W4254178405 hasLocation W42541784051 @default.
- W4254178405 hasOpenAccess W4254178405 @default.
- W4254178405 hasPrimaryLocation W42541784051 @default.
- W4254178405 hasRelatedWork W1994061350 @default.
- W4254178405 hasRelatedWork W1995476527 @default.
- W4254178405 hasRelatedWork W1998923065 @default.
- W4254178405 hasRelatedWork W2014956999 @default.
- W4254178405 hasRelatedWork W2016564814 @default.
- W4254178405 hasRelatedWork W2029688890 @default.
- W4254178405 hasRelatedWork W2098742882 @default.
- W4254178405 hasRelatedWork W2131811784 @default.
- W4254178405 hasRelatedWork W4236502113 @default.
- W4254178405 hasRelatedWork W1995193459 @default.
- W4254178405 hasVolume "12" @default.
- W4254178405 isParatext "false" @default.
- W4254178405 isRetracted "false" @default.
- W4254178405 workType "article" @default.